In this on-demand session, we discuss how rigorous biospecimen sourcing, characterization, and quality control standards underpin reliable translational insights. The presentation highlights how our global biobank, standardized workflows, and comprehensive clinical metadata enables confidence in downstream applications spanning multi-omics analysis, biomarker discovery, and therapeutic target validation.
What you’ll learn:
Whether your work centers on biomarker discovery, precision medicine, or translational validation, this webinar delivers a scientific perspective on how biospecimen quality directly impacts data fidelity and research outcomes. Learn how Crown Bioscience’s integrated quality systems provide the confidence required for regulatory-grade and translational applications.
Register now to view the full discussion and download the supporting materials.
Katharina Krohn, Senior Director, Global Biobanks, Crown Bioscience
Katharina Krohn leads Crown Bioscience’s Surgical Biobanking business including all global operations from the various clinical networks. Before joining the company, she was employed at the Center for Biochemistry and Molecular Cell Biology at the University Medical Center in Göttingen. Her work focused on molecular biology and protein biochemistry and protein biochemical experiments on the expression and purification of recombinant proteins. Katharina started within the pathology department as a technician in 2014, responsible for the coordination and execution of customer projects. Her first activities as a biobank manager began in 2016 resulting in the founding of today's Liquid Biopsy Biobank.
Your privacy is important to us.
We'll never share your information.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy
2025-11-06
2025-10-28
landing_page
Human Biospecimen Solutions